Pearls in Glaucoma Therapy Tanuj Dada, Parul Ichhpujani, George L Spaeth
INDEX
A
Acetazolamide 61
Acidosis 86
Adrenergic agonists 62
Adrenocortical insufficiency 83
Advanced glaucoma intervention study 11
Agranulocytosis 86
Alpha agonists 78
Amino acids 4
Anorexia 86
Antihypertensive medications 123
Anticardiolipin antibody 37
Antiglaucoma medications 61
Anxiety 128
Aplastic anemia 86
Apraclonidine 78, 79
Aspartate 4
Asthenia 86
Atypical band keratopathy 98
B
Benzalkonium chloride 74, 96
Beta-blockers 72
Betaxolol 72
Bimatoprost 61, 62
Biochemical theory 4
Blood
dyscrasia 86
flow 3
pressure 3, 5
charting 37
viscosity 3
Brimonidine 61, 78, 79
Brinzolamide 61
C
Caffeine 125
Carbonic anhydrase inhibitors 62, 82
Cardiovascular
accident 8
disease 13
Carotid Doppler testing 36
Carteolol 72
Central
corneal thickness 2, 10, 12, 19
nervous system 75
Cetrimide 97
Chlorhexidine digluconate 97
Chlorobutanol 97
Cholesterol 8
Cholinergics 62
Chronic
angle closure glaucoma 115
hyperemia secondary to latanoprost 65
Closed angle on gonioscopy 21
Collaborative
initial glaucoma treatment study 11
normal tension glaucoma study 120
Color vision disorder 86
Concept of glaucoma colored graph 40
Confusion 86
Congenital glaucoma 90
Conjunctival
changes 97
hyperemia 64
Continuous positive airway pressure therapy 125
Coronary heart disease 8
Cystoid macular edema 66
D
Deconsanoids 62
Decrease in blood supply to optic nerve head 2
Decreased libido 86
Depression 86, 128
Diabetes 5
mellitus 13
Dipivefrin 61
Direct acting cholinergic agents 89
Disc
damage likelihood scale 23, 24
hemorrhage 24
OD 26
OS 27
Distribution of IOP 9
Diurnal fluctuation of IOP 51
Dorzolamide 61
E
Early manifest glaucoma
treatment study 127
trial 10
Epinephrine 61
Erythema 86
multiforme 86
Extracellular matrix 3
Eye drops 113
Eyebrows 86
F
Factors influencing target IOP 50
First line therapy 104
Follicular conjunctivitis 98
G
Gastrointestinal disorder 86
Glaucoma 1, 123
colored graph 40
continuum 39
in pregnant and lactating patients 116
Glaucomatous
neuropathy 50
optic
nerve 9, 51
neuropathy 5
Globus hystericus 86
Glutamate 4, 5
mediated toxicity 4
Glycerin 93, 94
Glycerol 93
Glycosuria 86
Goldmann tonometer 19
Gonioscopy 20
Green zone 41
H
Heidelberg retinal tomography 26, 58
HRT
OD 53
OS 28, 54
printout 35
Humphry matrix FDP perimetry 34
Hypertension 8, 13
Hypertrichosis 65
Hypotension 13
Hypotensive lipids 62
I
Indirect acting anti-cholinesterase agents 89
Inferior RNFL defect 43
Inflammatory glaucomas 89
Intracranial hemorrhage 93
Intraocular pressure 1, 2, 19, 38, 123
Intrinsic sympathomimetic activity 74
IOP related damage 2
Iris color changes 65
Iritis 86
L
Latanoprost 61, 62
Level of IOP 9
Levobunolol 61, 72
Loss of eyelashes 86
Low
perfusion pressure 13
systemic blood pressure 4
systolic BP 13
tension glaucoma 36, 120
Lumigan 62
Lyell's syndrome 86
M
Malaise syndrome 86
Malignant glaucoma 90
Maximal tolerable medical therapy 104
Mechanical theory 2, 3
Methazolamide 86
Metipranolol 72
Migraine 13
Mild disease 51
Miotics 89
Mitochondrial metabolism 5
Moderate disease 51
Monoamine oxidase inhibitors 80
Monocular therapeutic trial 103
Multi drug therapy 99
Myocardial infarction 8
N
Natural history of glaucoma 39
Nausea 86
Necktie wear 127
Neovascular glaucoma 89, 119
Neuro-retinal rim 21
Normal
intraocular pressure 9
pressure glaucoma 36
tension glaucoma 2, 4
O
Obesity 8
OCT 29, 55
Ocular
beta-blockers 72
cicatricial pemphigoid 98
hypertension 2
treatment study 10
hypotensive medications 61
surface health 129
Open
angle
glaucoma 61
on gonioscopy 21
anterior chamber angles 2
disc 1
color and red free photos 32
nerve
damage 59
head evaluation 21
Optical coherence tomography 26
Oral carbonic anhydrase inhibitors 61
P
Paresthesia 86
Pathogenesis of glaucoma 2
Pediatric glaucomas 116
Perfusion pressure 3
Periocular dermatitis 99
Periorbital
dermatitis with brimonidine 80
skin hyperpigmentation 65
Physostigmine 61
Pilocarpine 61
Pilocarpus microphyllus 89
Polypharmacy era 61
Polyuria 86
Pregnancy 66
Preperimetric glaucoma 2
Pressure-cornea-vascular index 20
Pressure-to-cornea index 19
Primary
angle closure
disease 1
glaucoma 115
open angle glaucoma 1, 2
Progression of glaucomatous optic neuropathy 25
Progressive optic neuropathy 2
Prostaglandin analogs 61, 62
Prostamide 62
R
Red zone 41
Refractive error 13
Renal disorder 86
Retinal
ganglion cells 2
nerve fiber 1, 40
RNFL defect 43
S
Scanning laser polarimetry 26
Severe disease 51
Shirshasana yoga posture 128
Significant respiratory disease 83
Sleep
apnea 5
disordered breathing 125
Somnolence 86
Squamous metaplasia 97
STAR calculator 15
Stevens-Johnson syndrome 86
Subconjunctival fibrosis 98
Subepithelial fibrosis 97
Synechial angle closure 48
Systemic disease 13
T
Tafluoprost 62
Tenon's capsule 98
Tentatively assigned target pressure 51
Thrombocytopenia 86
Timolol 61, 72
Topical carbonic anhydrase inhibitors 61
Travoprost 61, 62, 67
U
Unoprostone 61
isopropyl 62
Urolithiasis 86
Urticaria 86
Uveitic glaucoma 118
V
Vascular theory 4
Visual field
abnormalities 51
loss 39
OD 30, 46, 56
OS 31, 33, 47, 57
testing 25
Vomiting 86
W
Weight loss 86
White-on-white perimetry 25
X
Xovatra 67
Y
Yellow zone 41
Yoga 127
×
Chapter Notes

Save Clear